ArticleBMC cancer2025
Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft.
Pinsheng Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it